stockrowCibus, Inc. (CBUS) vs VAXART, INC. (VXRT)
- Cibus, Inc. CBUS 1.16 −6.45%
- VAXART, INC. VXRT 0.37 −7.50%
Cibus, Inc. and VAXART, INC. are both Biotechnology companies. Cibus, Inc. and VAXART, INC. are of similar size ($94.8M and $92.4M). Cibus, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. grew revenue faster over the last twelve months: 22.3% against −10.3%. VAXART, INC. has the higher net margin (16.0% vs −2,258.9%) and the higher return on invested capital (2,542.3% vs 0.00%). Across the 17 metrics below, VAXART, INC. leads on 17 and Cibus, Inc. on 0.
Valuation
Profitability
| Metric | CBUS | VXRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (1,450.59%) | 16.63% | 0.00% |
| Net margin | (2,258.89%) | 16.02% | 0.00% |
| Free cash flow margin | (1,064.60%) | 17.64% | 0.00% |
| Return on equity | (219.97%) | 62.42% | (50.12%) |
| Return on assets | (29.77%) | 16.26% | (45.60%) |
| Return on invested capital | 0.00% | 2,542.26% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack